Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy
JCEM Case Reports · 23.02.2026 · 4 (3)
DOI: 10.1210/jcemcr/luag041 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 18.03.2026. Verfasst von Kasra Emami und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Cancer immunotherapies have a class of medications called checkpoint inhibitors that can induce endocrinopathies including hypothyroidism, hypophysitis, and adrenalitis. This case illustrates a 72-year-old woman with recently diagnosed non-small cell lung cancer (NSCLC) who developed immune-mediated hypothyroidism and subsequent type 1 diabetes mellitus (T1DM) presenting as diabetic ketoacidosis (DKA) after 3 months of combination immunotherapy with nivolumab and ipilimumab. After her hospitalization, she was discharged on insulin. Our clinical case not only provides more literature on the risks involved with immunotherapy but also shows a rare outcome with checkpoint inhibitor–induced T1DM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA.
ORCID-Profile: Kasra Emami
Zitieren
APA
Emami, K., Goyal, S., Akula, V., & Amoakohene, P. (2026). Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy. JCEM Case Reports, 4(3). https://doi.org/10.1210/jcemcr/luag041
Vancouver
Emami K, Goyal S, Akula V, Amoakohene P. Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy. JCEM Case Reports. 2026;4(3). doi:10.1210/jcemcr/luag041
BibTeX
@article{Emami2026,
author = {Emami, Kasra and Goyal, Sonia and Akula, Vishal and Amoakohene, Peggy},
title = {Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy},
journal = {JCEM Case Reports},
year = {2026},
volume = {4},
number = {3},
doi = {10.1210/jcemcr/luag041}
}
EUVIMED